Brief: Polypid Announces Positive FDA Pre-NDA Meeting Minutes
03/12/2025 13:33
Dec 3 (Reuters) - PolyPid Ltd PYPD.O: POLYPID ANNOUNCES POSITIVE FDA PRE-NDA MEETING MINUTES FOR D-PLEX₁₀₀ SUPPORTING NDA SUBMISSION POLYPID LTD - FDA AGREED TO A ROLLING NDA REVIEW, ALLOWING POLYPID TO SUBMIT FIRST COMPLETED SECTIONS IN EARLY 2026 Source text: ID:nGNX38d4TG Further company coverage: PYPD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Polypid
See all newsPolyPid Ltd reports results for the quarter ended June 30 - Earnings Summary
PolyPid Ltd expected to post a loss of 38 cents a share - Earnings Preview
Brief: Polypid Announces FDA Acceptance Of NDA With Priority Review For D-Plex₁₀₀
PolyPid, Azurity sign surgical site infection drug deal
Brief: Polypid Initiates D-Plex₁₀₀ NDA Submission To The FDA